Drug reformulation may improve treatment of Niemann-Pick type C disease [PreClinical]
1. The authors developed a triple combination formula (TCF) with three components: the histone deacetylase inhibitor vorinostat (Vo), 2-Hydroxypropyl-β-cyclodextrin (HPBCD), ...